trending Market Intelligence /marketintelligence/en/news-insights/trending/6dGehkxaT70Gk4n-HIryRQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Emerald Health closes investment in Abattis Bioceuticals unit

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Emerald Health closes investment in Abattis Bioceuticals unit

Emerald Health Therapeutics Inc. completed its previously announced acquisition of a 53% interest in Northern Vine Canada Inc., a unit of Abattis Bioceuticals Corp.

Emerald Health invested C$2.5 million into Northern Vine for the ownership interest. The company will also appoint three of its four directors.

Abattis will continue to own the remaining 47% of Northern Vine.